Biologic Therapy of Inflammatory Bowel Disease. Antibody against TNF - Infliximab - inChildren
Authors:
J. Malý 1; J. Krejsek 2; O. Pozler
Authors‘ workplace:
Dětská klinika FN a LF, Hradec Králové1 přednostka doc. MUDr. E. Pařízková, CSc. Ústav klinické imunologie a alergologie FN a LF, Hradec Králové2 přednosta MUDr. O. Kopecký, CSc.
Published in:
Čes-slov Pediat 2003; (8): 0.
Category:
Overview
The authors present recent information about biologic therapy of inflammatory bowel disease (IBD) in children.Antibody against tumor necrosis alfa - infliximab and it’s side effects is especially brought up.
Key words:
biologic therapy, infliximab, IBD, children
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2003 Issue 8
Most read in this issue
- Killian-Pallister Syndrome of Postzygotic Mutation
- Serum Levels of Insulin Like Growth Factor-1 (IGF-1) in Normal Healthy Children Youngerthan 2 Years of Age
- Neonatal Neoplasms
- Idiopathic Osteolysis